169 related articles for article (PubMed ID: 19879869)
21. Differential effects of lesions in the subareas of medial prefrontal cortex on the development of behavioral sensitization to amphetamine: the role of environmental context.
Liao RM; Lin HL
Chin J Physiol; 2008 Dec; 51(6):394-401. PubMed ID: 19280884
[TBL] [Abstract][Full Text] [Related]
22. Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization.
Panayi F; Colussi-Mas J; Lambás-Señas L; Renaud B; Scarna H; Bérod A
Neuropsychopharmacology; 2005 May; 30(5):871-9. PubMed ID: 15637639
[TBL] [Abstract][Full Text] [Related]
23. Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat.
Wunderlich GR; DeSousa NJ; Vaccarino FJ
Psychopharmacology (Berl); 2000 Aug; 151(2-3):283-90. PubMed ID: 10972475
[TBL] [Abstract][Full Text] [Related]
24. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists.
Wolf ME; Dahlin SL; Hu XT; Xue CJ; White K
Neuroscience; 1995 Nov; 69(2):417-39. PubMed ID: 8552239
[TBL] [Abstract][Full Text] [Related]
25. D1 dopamine receptor blockade prevents the facilitation of amphetamine self-administration induced by prior exposure to the drug.
Pierre PJ; Vezina P
Psychopharmacology (Berl); 1998 Jul; 138(2):159-66. PubMed ID: 9718285
[TBL] [Abstract][Full Text] [Related]
26. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine.
Li Y; Vartanian AJ; White FJ; Xue CJ; Wolf ME
Psychopharmacology (Berl); 1997 Dec; 134(3):266-76. PubMed ID: 9438676
[TBL] [Abstract][Full Text] [Related]
27. Effects of Delta 9-tetrahydrocannabinol, (R)-methanandamide, SR 141716,and d-amphetamine before and during daily Delta 9-tetrahydrocannabinol dosing.
Lamb RJ; Järbe TU; Makriyannis A; Lin S; Goutopoulos A
Eur J Pharmacol; 2000 Jun; 398(2):251-8. PubMed ID: 10854837
[TBL] [Abstract][Full Text] [Related]
28. Evidence for dissociable mechanisms of amphetamine- and stress-induced behavioral sensitization: effects of MK-801 and haloperidol pretreatment.
Tolliver BK; Ho LB; Reid MS; Berger SP
Psychopharmacology (Berl); 1996 Aug; 126(3):191-8. PubMed ID: 8876018
[TBL] [Abstract][Full Text] [Related]
29. Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulants.
Tolliver BK; Ho LB; Reid MS; Berger SP
J Pharmacol Exp Ther; 1996 Jul; 278(1):411-20. PubMed ID: 8764377
[TBL] [Abstract][Full Text] [Related]
30. Differential behavioral responses to chronic amphetamine in adult male and female rats exposed to postnatal cocaine treatment.
Melnick SM; Dow-Edwards DL
Pharmacol Biochem Behav; 2001; 69(1-2):219-24. PubMed ID: 11420089
[TBL] [Abstract][Full Text] [Related]
31. Effects of naltrexone on amphetamine-induced locomotion and rearing: acute and repeated injections.
Balcells-Olivero M; Vezina P
Psychopharmacology (Berl); 1997 Jun; 131(3):230-8. PubMed ID: 9203233
[TBL] [Abstract][Full Text] [Related]
32. Significance of glutamate and dopamine neurons in the ventral pallidum in the expression of behavioral sensitization to amphetamine.
Chen JC; Liang KW; Huang YK; Liang CS; Chiang YC
Life Sci; 2001 Jan; 68(9):973-83. PubMed ID: 11212872
[TBL] [Abstract][Full Text] [Related]
33. Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics.
Drouin C; Blanc G; Villégier AS; Glowinski J; Tassin JP
Synapse; 2002 Jan; 43(1):51-61. PubMed ID: 11746733
[TBL] [Abstract][Full Text] [Related]
34. Factors that determine a propensity for cocaine-seeking behavior during abstinence in rats.
Sutton MA; Karanian DA; Self DW
Neuropsychopharmacology; 2000 Jun; 22(6):626-41. PubMed ID: 10788762
[TBL] [Abstract][Full Text] [Related]
35. Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine.
Tolliver BK; Ho LB; Fox LM; Berger SP
J Pharmacol Exp Ther; 1999 Apr; 289(1):38-47. PubMed ID: 10086985
[TBL] [Abstract][Full Text] [Related]
36. Involvement of Glutamate NMDA Receptors in the Acute, Long-Term, and Conditioned Effects of Amphetamine on Rat 50 kHz Ultrasonic Vocalizations.
Costa G; Morelli M; Simola N
Int J Neuropsychopharmacol; 2015 May; 18(11):pyv057. PubMed ID: 25991653
[TBL] [Abstract][Full Text] [Related]
37. Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area.
Vezina P; Queen AL
Psychopharmacology (Berl); 2000 Aug; 151(2-3):184-91. PubMed ID: 10972464
[TBL] [Abstract][Full Text] [Related]
38. Chronic pretreatment with methylphenidate induces cross-sensitization with amphetamine.
Yang PB; Swann AC; Dafny N
Life Sci; 2003 Oct; 73(22):2899-911. PubMed ID: 14511774
[TBL] [Abstract][Full Text] [Related]
39. Individual differences in amphetamine sensitization, behavior and central monoamines.
Scholl JL; Feng N; Watt MJ; Renner KJ; Forster GL
Physiol Behav; 2009 Mar; 96(3):493-504. PubMed ID: 19103211
[TBL] [Abstract][Full Text] [Related]
40. Contribution of drug doses and conditioning periods to psychomotor stimulant sensitization.
Todtenkopf MS; Carlezon WA
Psychopharmacology (Berl); 2006 May; 185(4):451-8. PubMed ID: 16550389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
